Clinical trials
Recruiting Observational Pancreatic Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
154 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2002 | 1 |
| 2004 | 2 |
| 2008 | 2 |
| 2013 | 4 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 9 |
| 2017 | 4 |
| 2018 | 8 |
| 2019 | 2 |
| 2020 | 10 |
| 2021 | 10 |
| 2022 | 21 |
| 2023 | 17 |
| 2024 | 18 |
| 2025 | 21 |
| 2026 | 17 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 154 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Changhai Hospital | 4 |
| IRCCS San Raffaele | 4 |
| Imperial College London | 4 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 3 |
| Mayo Clinic | 3 |
| Memorial Sloan Kettering Cancer Center | 3 |
| Nuvance Health | 3 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 3 |
| Abramson Cancer Center at Penn Medicine | 2 |
| AstraZeneca | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Neoplasms | 154 |
| Neoplasms | 21 |
| Stomach Neoplasms | 20 |
| Colorectal Neoplasms | 19 |
| Lung Neoplasms | 16 |
| Pancreatic Diseases | 16 |
| Esophageal Neoplasms | 15 |
| Liver Neoplasms | 14 |
| Ovarian Neoplasms | 14 |
| Pancreatic Cyst | 14 |
Trials
Showing 1 to 25 of 154. Each trial links to its page on Pharma Observatory.
54 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.